Morla A, Ruoslahti E
Cancer Research Center, La Jolla Cancer Research Foundation, California 92037.
J Cell Biol. 1992 Jul;118(2):421-9. doi: 10.1083/jcb.118.2.421.
The active form of fibronectin is its extracellular matrix form, which allows for the attachment of cells and influences both the growth and migration of cells. The matrix form is assembled by cells; however, many cells are defective in this regard. Several regions within fibronectin have been shown to play a role in matrix assembly by cells. One such region has been localized into the first type III repeat of fibronectin (Chernousov, M. A., F. J. Fogerty, V. E. Koteliansky, and D. F. Mosher. J. Biol. Chem. 266:10851-10858). We have identified this site as a fibronectin-fibronectin binding site and reproduced it as a synthetic peptide. This site is contained in a 14-kD fragment that corresponds to portions of the first two type III repeats. The 14-kD fragment was found to bind to cell monolayers and to inhibit fibronectin matrix assembly. The 14-kD fragment only slightly reduced the binding of fibronectin to cell surfaces but it significantly inhibited the subsequent incorporation of fibronectin into the extracellular matrix. The 14-kD fragment also bound to purified fibronectin and inhibited fibronectin-fibronectin binding. A synthetic 31-amino acid peptide (P1) representing a segment of the 14-kD fragment retained the ability to inhibit fibronectin-fibronectin binding. Peptide P1 specifically bound fibronectin from plasma in affinity chromatography, whereas a column containing another peptide from the 14-kD fragment did not. These results define a fibronectin-fibronectin binding site that appears to promote matrix assembly by allowing the assembly of fibronectin molecules into nascent fibrils. The 14-kD fragment and the P1 peptide that contain this site inhibit matrix assembly by competing for the fibronectin-fibronectin binding.
纤连蛋白的活性形式是其细胞外基质形式,它能使细胞附着,并影响细胞的生长和迁移。基质形式由细胞组装而成;然而,许多细胞在这方面存在缺陷。纤连蛋白内的几个区域已被证明在细胞的基质组装中发挥作用。其中一个区域已定位到纤连蛋白的第一个III型重复序列中(切尔诺苏夫,M. A.,F. J. 福格蒂,V. E. 科捷良斯基,和D. F. 莫舍。《生物化学杂志》266:10851 - 10858)。我们已将该位点鉴定为纤连蛋白 - 纤连蛋白结合位点,并将其复制为合成肽。该位点包含在一个14-kD片段中,该片段对应于前两个III型重复序列的部分。发现14-kD片段能与细胞单层结合并抑制纤连蛋白基质组装。14-kD片段仅略微降低了纤连蛋白与细胞表面的结合,但它显著抑制了随后纤连蛋白掺入细胞外基质。14-kD片段也能与纯化的纤连蛋白结合并抑制纤连蛋白 - 纤连蛋白结合。一个代表14-kD片段一段的31个氨基酸的合成肽(P1)保留了抑制纤连蛋白 - 纤连蛋白结合的能力。在亲和色谱中,肽P1特异性结合血浆中的纤连蛋白,而含有来自14-kD片段另一个肽的柱子则不能。这些结果定义了一个纤连蛋白 - 纤连蛋白结合位点,该位点似乎通过允许纤连蛋白分子组装成新生纤维来促进基质组装。包含该位点的14-kD片段和P1肽通过竞争纤连蛋白 - 纤连蛋白结合来抑制基质组装。